Burke PJ - Search Results

1

Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.

Kaufmann SH, Charron M, Burke PJ, Karp JE. Kaufmann SH, et al. Among authors: burke pj. Cancer Res. 1995 Mar 15;55(6):1255-60. Cancer Res. 1995. PMID: 7882318

2

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: burke pj. Cancer Res. 1989 Aug 15;49(16):4640-7. Cancer Res. 1989. PMID: 2568175

3

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.

Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. Geller RB, et al. Among authors: burke pj. Cancer. 1989 Aug 1;64(3):629-34. doi: 10.1002/1097-0142(19890801)64:3<629::aid-cncr2820640311>3.0.co;2-l. Cancer. 1989. PMID: 2743258

4

Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia.

Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Kaufmann SH, et al. Among authors: burke pj. Blood. 1994 Jan 15;83(2):517-30. Blood. 1994. PMID: 7904487 Free article.

5

Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ. Kaufmann SH, et al. Among authors: burke pj. Cancer Res. 1991 Jul 1;51(13):3534-43. Cancer Res. 1991. PMID: 1647269

6

A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.

Gore SD, Rowinsky EK, Miller CB, Griffin C, Chen TL, Borowitz M, Donehower RC, Burks KL, Armstrong DK, Burke PJ, Grever MR, Kaufmann SH. Gore SD, et al. Among authors: burke pj. Clin Cancer Res. 1998 Nov;4(11):2677-89. Clin Cancer Res. 1998. PMID: 9829730 Clinical Trial.

7

Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.

Karp JE, Burke PJ, Donehower RC. Karp JE, et al. Among authors: burke pj. Leukemia. 1990 Aug;4(8):553-6. Leukemia. 1990. PMID: 2201833

8

Cutaneous eruptions of lymphocyte recovery.

Horn TD, Redd JV, Karp JE, Beschorner WE, Burke PJ, Hood AF. Horn TD, et al. Among authors: burke pj. Arch Dermatol. 1989 Nov;125(11):1512-7. Arch Dermatol. 1989. PMID: 2684020

9

In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia.

Karp JE, Donehower RC, Enterline JP, Dole GB, Fox MG, Burke PJ. Karp JE, et al. Among authors: burke pj. Blood. 1989 Jan;73(1):24-30. Blood. 1989. PMID: 2910362 Free article.

10

Drug induced host factors which stimulate growth of residual leukemia in Lewis x Brown Norway F1 (LEW-BN) rats.

Burke PJ, Karp JE, Saylor PL. Burke PJ, et al. Cancer Res. 1986 Apr;46(4 Pt 1):1813-6. Cancer Res. 1986. PMID: 3485014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters